International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of all issues and individual articles published by the Journal since 1997.

LEARN MORE

Calculations

Author(s): Stockton Shelly J

Issue: Mar/Apr 2020 - Volume 24, Number 2
View All Articles in Issue

Page(s): 128

Download in electronic PDF format for $75

Abstract:

Related Keywords: estradiol patch, transdermal administration, drug release rate, ophthalmic solution

Related Categories: HRT, OPHTHALMICS, DOSAGE FORMS/DRUG CARRIERS

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Veterinary Transdermal Medications: A to Z Davidson Gigi S	Mar/Apr 2003 Pg. 106-113
The Influence of Polymers, Surfactants, and Other Excipients on Naproxen Sodium Release from Matrices Prepared and the Effect of These Additives on the Swelling Rate of the Tablet Alhmoud Hassan, Akkam Yazan, Omari Derar, Alghananim Alaa, Melhem Mohammad Bani	Sep/Oct 2023 Pg. 431-439
Calculations Prince Shelly J	Jul/Aug 2003 Pg. 294
Calculations Stockton Shelly J	Mar/Apr 2020 Pg. 128
Basics of Sterile Compounding: Ophthalmic Preparations, Part 1: Ophthalmic Solutions Allen Loyd V Jr	Sep/Oct 2016 Pg. 399-404
Kinetic Analysis of Drug Release from Compounded Slow-release Capsules of Liothyronine Sodium (T3) Bakhteyar Hamid, Cassone Clayton, Kohan Hamed Gilzad, Sani Shabnam N	Sep/Oct 2017 Pg. 418-425
Three Fortified Ophthalmic Solutions: Amikacin 5% Ophthalmic Solution; Ceftazidime 5% Ophthalmic Solution; Vancomycin 5% Ophthalmic Solution Allen Loyd V Jr	Sep/Oct 2010 Pg. 421
Compounding Slow-release Capsules: A Comprehensive Review and an Excel Spreadsheet for Faster Calculation of Excipients Zur Eyal	Jan/Feb 2013 Pg. 10-22
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs Allen Loyd V Jr	Sep/Oct 2017 Pg. 356
Drug-release Assessment of Compounded Topical Nifedipine and Diltiazem in Commonly Used Bases for Wound Healing Teimouri Arezou, Yeung Pollen, Agu Remigius U	Nov/Dec 2020 Pg. 501-508
Three Fortified Ophthalmic Solutions: Amikacin 5% Ophthalmic Solution; Ceftazidime 5% Ophthalmic Solution; Vancomycin 5% Ophthalmic Solution	Jan/Feb 2025 Pg. 51
Basics of Sterile Compounding: Biopharmaceutics of Injectable Dosage Forms Akers Michael J	Jan/Feb 2017 Pg. 47-56
Basics of Compounding: Compounding Irrigation Solutions for Sterile and Nonsterile Preparations Allen Loyd V Jr	Nov/Dec 2017 Pg. 481-486
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines Allen Loyd V Jr	Jul/Aug 2016 Pg. 351 View Sample
Calculations Prince Shelly J	Jul/Aug 2002 Pg. 305
Compatibility Screening of Bivalirudin During Simulated Y-Site Administration with Other Drugs Trissel Lawrence A, Saenz Christopher	Jul/Aug 2002 Pg. 311-315
Standard Operating Procedure: U.S. Food and Drug Administration Inspection--Releasing a Sample to the U.S. Food and Drug Administration Kupiec Tom, Kemp Jesse	Jul/Aug 2007 Pg. 326-327
Bilateral Areolar Hyperpigmentation Following Transdermal Administration of Compounded Hormone Replacement Therapy Griffee Chris, Delano Amy	Mar/Apr 2012 Pg. 110-114
Dexamethasone Sodium Phosphate Ophthalmic Solution: Equivalent to 0.1% Dexamethasone Phosphate Allen Loyd V Jr	Nov/Dec 2015 Pg. 508
Basics of Compounding: 3D Printing--Pharmacy Applications: Geometric Shape Effects on 3D Printing Allen Loyd V Jr	Sep/Oct 2017 Pg. 388-392
Return to Top